AMWL - NYSE

American Well Corporation

AMWL·NYSE

$8.46

+0.65%

HealthcareMedical - Healthcare Information Services

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$141.35M

EPS-5.9600

P/E Ratio-1.42

Earnings Date08/04/2026

323.79M

Assets

-26%

3Y-73.0%

5Y-76.0%

10Y-34.0%

76.00M

Total Liabilities

-37%

3Y-43.0%

5Y-42.0%

10Y-89.0%

247.79M

Total Equity

-22%

3Y-77.0%

5Y-80.0%

10Y-221.0%

American Well Corporation Funding & Solvency Profile

AMWL · NYSE

Current Assets

Cash & Cash Equivalents182.33M

Net Receivables49.69M

Inventory1.19M

Other Current Assets13.47M

Total Current Assets247 M

Non-Current Assets

Property, Plant & Equipment4.16M

Goodwill & Intangible Assets66.07M

Long-Term Investments795.00K

Other Non-Current Assets6.08M

Total Non-Current Assets11 M

Total Assets

323.79M

Financial Health Analysis

Current Ratio

3.37x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.31x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

173 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

76% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

American Well Corporation Balance Sheet

AMWL • NYSE

American Well Corporation Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	182.3M	228.3M	372M	538.5M	746.4M	941.6M	137.7M	48M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	100M	40M	208.2M
Cash & Short-Term Investments	182.3M	228.3M	372M	538.5M	746.4M	1B	177.6M	256.2M
Net Receivables	49.7M	71.9M	54.1M	58.4M	51.4M	45.3M	32.7M	30.8M
Accounts Receivables	49.7M	71.9M	54.1M	58.4M	51.4M	45.3M	32.7M	30.8M
Inventory	1.2M	2.9M	6.7M	8.7M	7.5M	9.1M	3.1M	2.5M
Prepaids	0.0	0.0	0.0	19.6M	20.3M	14.1M	7.2M	4.8M
Other Current Assets	13.5M	13.9M	16.7M	1.4M	1.7M	3.2M	2.9M	5.9M
Total Current Assets	246.7M	317M	449.6M	626.6M	827.3M	1.1B	223.5M	300.2M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	4.2M	7.6M	11M	14.5M	18.7M	10.4M	14.6M	3.1M
Goodwill	0.0	0.0	0.0	435.3M	442.8M	193.9M	193.9M	127.3M
Intangible Assets	66.1M	101.5M	120.2M	135M	152.4M	55.5M	63.5M	55.4M
Goodwill & Intangible Assets	66.1M	101.5M	120.2M	570.3M	595.2M	249.4M	257.4M	182.7M
Long-Term Investments	795K	1.5M	1.2M	795K	168K	752K	1.1M	1.1M
Tax Assets	0.0	0.0	0.0	-795K	2M	1.3M	-1.1M	-1.1M
Other Non-Current Assets	6.1M	8.4M	7.7M	6.2M	2.5M	1.4M	4.3M	3.4M
Total Non-Current Assets	77.1M	119M	140.1M	590.9M	618.5M	263.4M	276.4M	189.1M
Total Assets	323.8M	436M	589.7M	1.2B	1.4B	1.4B	499.9M	489.3M
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.6M	5M	4.9M	7.2M	12.2M	5.8M	6.5M	4.2M
Accounts Payable	1.6M	5M	4.9M	7.2M	12.2M	5.8M	6.5M	4.2M
Accrued Expenses	10.6M	13.3M	26.8M	18.3M	43.7M	42.1M	27.4M	11.2M
Capital Lease Obligations (Current)	3.6M	3.7M	3.6M	3.1M	1.9M	6.4M	6.2M	0.0
Deferred Revenue	22.6M	53.2M	46.4M	49.5M	0.0	0.0	66.5M	64.1M
Other Current Liabilities	34.7M	36.1M	12.1M	36M	83.8M	66.7M	66.5M	8.3M
Total Current Liabilities	73.2M	111.3M	93.8M	114.1M	141.6M	121M	106.6M	87.8M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	-655.8M	0.0
Deferred Revenue (Non-Current)	818K	2.8M	6.1M	6.3M	7.1M	8.1M	10.9M	29.2M
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	655.8M	0.0
Other Non-Current Liabilities	1.1M	1.2M	1.4M	1.6M	21.6M	64K	-655.5M	576.7M
Total Non-Current Liabilities	2.8M	8.5M	15.7M	19.7M	43.3M	9.5M	674.2M	605.9M
Capital Lease Obligations	4.5M	8.2M	11.8M	14.8M	16.6M	7.7M	13.4M	0.0
Total Liabilities	76M	119.7M	109.5M	133.7M	185M	130.4M	780.7M	693.7M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	0.0	-37.6M	-158K	-36.8M
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	655.8M	575.7M
Common Stock	165K	156K	145K	2.8M	2.6M	2.4M	423K	414K
Additional Paid-In Capital	2.3B	2.3B	2.2B	2.2B	2.1B	1.8B	50.3M	37.1M
Retained Earnings	-2.1B	-2B	-1.8B	-1.1B	-811.3M	-582.4M	-357.9M	-270.7M
Accumulated Other Comprehensive Income/Loss	-12.1M	-15.8M	-15.7M	-17M	-6.4M	297K	250K	1.4M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-575.3M
Total Stockholders' Equity	235.6M	304.8M	464.2M	1.1B	1.2B	1.2B	-307.1M	-231.8M
Total Equity	247.8M	316.2M	480.2M	1.1B	1.3B	1.2B	-280.9M	-204.4M
Minority Interest	12.2M	11.5M	16M	20M	21.6M	22.1M	26.3M	27.4M
SUMMARY
Total Liabilities & Equity	323.8M	436M	589.7M	1.2B	1.4B	1.4B	499.9M	489.3M
Total Investments	795K	1.5M	1.2M	795K	168K	100.7M	40M	208.2M
Total Debt	4.5M	8.2M	11.8M	14.8M	16.6M	7.7M	13.4M	0.0
Net Debt	-177.8M	-220.1M	-360.3M	-523.7M	-729.8M	-934M	-124.3M	-48M
Shares Outstanding	16,152,178	16,152,178	16,152,178	16,152,178	16,152,178	16,152,178	16,152,178	16,152,178

SEC Filings

AMWL - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 12, 2026	May 06, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 23, 2026	April 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 02, 2026	April 01, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 12, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 12, 2026	February 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 08, 2026	January 05, 2026	2026	View Filing
8-K 8-K 2025 N/A	January 02, 2026	December 24, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 04, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 94 filings

Related Guides

Blog Categories

Continue your AMWL research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.